HDFC Pharma and Healthcare Fund - Direct Plan - Growth

Regular

Regular and Direct options of the funds are exactly same except commission to your mutual fund broker/distributor. As an investor you do not need to pay any additional fees to purchase any of these options. However both have different expense ratios. Regular funds have higher expense ratio and direct funds have lower expense ratio. This difference is because of commission paid to broker/distributor. Lower expense ratio leads to higher returns for investors.
Direct

Regular and Direct options of the funds are exactly same except commission to your mutual fund broker/distributor. As an investor you do not need to pay any additional fees to purchase any of these options. However both have different expense ratios. Regular funds have higher expense ratio and direct funds have lower expense ratio. This difference is because of commission paid to broker/distributor. Lower expense ratio leads to higher returns for investors.

Category : Sectoral/Thematic

Fund House : HDFC Mutual Fund

NAV

This number shows latest NAV (Net Asset Value) and change in the NAV from previous day. NAV is nothing but the unit price for the fund. You will be allocated number of units based on this price. NAV is declared once each day generally at the end of the day. Once you invest in mutual funds, your money is further invested in stocks and bonds by mutual fund managers. Mutual Fund NAV is the per unit latest value of all such stocks/bonds held in the portfolio

: ₹ 18.076 0.9%
(as on 19th September, 2025)

Crisil Rating

Not Rated

Rank not available for the fund

Fund Size

: ₹ 1909.3 Cr

(0.38% of Investment in Category)

Expense Ratio

: 0.88%

(0.89% Category average)

Risk-O-Meter

Very High Risk

Sectoral/Thematic :Sectoral/Thematic : The fund has 98.89% investment in domestic equities of which 31.98% is in Large Cap stocks, 17.47% is in Mid Cap stocks, 10.95% in Small Cap stocks.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

1M
3M
6M
1Y
2Y
5Y
ALL

This Scheme

VS

Benchmark
BSE Healthcare TRI

0%

0%

0%

0%

0%

0%

0%
NA
2.36%

5.57%

15.19%

0.91%

20.27%

23.65%

14.82%

NA
Gold

Compare with

Date : -
NAV : -

1M
3M
6M
9M
1Y
2Y
3Y
5Y
ALL

Date : -
Investment : -
Value on selected date : -

Returns Calculator
SIP Calculator
VIP (Value Avg)

Amount

₹

Investment Date
Sell Date

Investment Value

-
Sell Value

-
Profit/Loss

-
Annualised Returns

-

Date : -
Investment : -
Value on selected date : -

Returns (NAV as on 19th September, 2025)

Period Invested for	₹10000 Invested on	Latest Value	Absolute Returns	Annualised Returns	Category Avg	Rank within Category
1 Week	12-Sep-25	10121.50	1.22%	-	1.40%	136/226
1 Month	19-Aug-25	10163.60	1.64%	-	2.36%	148/224
3 Month	19-Jun-25	10893.10	8.93%	-	5.57%	35/216
6 Month	19-Mar-25	11256.70	12.57%	-	15.19%	149/212
YTD	01-Jan-25	10417.20	4.17%	-	4.93%	102/201
1 Year	19-Sep-24	11188.40	11.88%	11.88%	0.91%	11/179
Since Inception	04-Oct-23	18139.50	81.40%	35.47%	14.82%	3/198

Returns Calculator Detailed Returns Analysis

SIP Returns (NAV as on 19th September, 2025)

Period Invested for	₹1000 SIP Started on	Investments	Latest Value	Absolute Returns	Annualised Returns
1 Year	19-Sep-24	12000	13111.51	9.26 %	17.55 %

SIP Calculator Detailed Returns Analysis

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.

Portfolio (Updated on 31st Aug,2025)

Portfolio Turnover Ratio : 33.07% | Category average turnover ratio is 154.05%

Fund manager updated portfolio less frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for longer duration than peers)

Equity Holding : 98.89% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 98.89%

No of Stocks : 29 (Category Avg - 44.44) | Large Cap Investments : 31.98%| Mid Cap Investments : 17.47% | Small Cap Investments : 10.95% | Other : 38.49%

Top 10 Stocks in Portfolio

How to read this table?

Stock Invested in	Sector	Value(Mn)	% of Total Holdings	1M Change	1Y Highest Holding	1Y Lowest Holding	Quantity	1M Change in Qty
Sun Pharmaceutical Industries Ltd.	Pharmaceuticals	1984.6	10.39%	-0.58%	14.02% (Oct 2024)	10.39% (Aug 2025)	12.45 L	0.00
Divis Laboratories Ltd.	Pharmaceuticals	1584.9	8.30%	-0.51%	10.24% (May 2025)	7.18% (Dec 2024)	2.58 L	0.00
Glenmark Pharmaceuticals Ltd.	Pharmaceuticals	1294.4	6.78%	-0.64%	7.42% (Jul 2025)	2.84% (Sep 2024)	6.73 L	0.00
Lupin Ltd.	Pharmaceuticals	1285.3	6.73%	0.75%	6.73% (Aug 2025)	5.32% (Sep 2024)	6.78 L	78.55 k
Cipla Ltd.	Pharmaceuticals	1253	6.56%	0.23%	8.17% (Oct 2024)	5.48% (Sep 2024)	7.88 L	0.00
Ipca Laboratories Ltd.	Pharmaceuticals	882.2	4.62%	0.25%	4.62% (Aug 2025)	3.26% (Jan 2025)	6.37 L	62.77 k
Alkem Laboratories Ltd.	Pharmaceuticals	751.4	3.94%	0.95%	3.94% (Aug 2025)	0% (Sep 2024)	1.42 L	26.50 k
Torrent Pharmaceuticals Ltd.	Pharmaceuticals	714.1	3.74%	-0.14%	3.88% (Jul 2025)	2.26% (Oct 2024)	2.01 L	0.00
Krishna Institute of Medical Sciences Ltd.	Hospital	712.8	3.73%	-0.09%	4.04% (Mar 2025)	3.25% (Oct 2024)	9.85 L	0.00
Laurus Labs Ltd.	Pharmaceuticals	691	3.62%	-0.02%	3.64% (Jul 2025)	0% (Sep 2024)	8.06 L	0.00

- indicates change in weight in the portfolio. # indicates a new entry.

Detailed Portfolio Analysis

Name	Type of Instrument	Weight (%)
TREPS	TREPS	1.03%
Net Receivables	Net Receivables	0.08%

Detailed Portfolio Analysis

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)

No data available. Ratios are only available for the funds which are 3 years old.

Alternative Funds (Category Peers)

Scheme Name	Crisil Rank	Asset Size (Cr)	1M	3M	6M	1Y	3Y
Nippon India Taiwan Equity Fund - Direct Plan - Growth	NA	389.09	11.25	31.11	55.96	49.03	35.42
Aditya Birla Sun Life International Equity Fund - Direct Plan - Growth	NA	249.75	4.03	12.03	18.03	26.90	19.28
HDFC Defence Fund - Direct Plan - Growth	NA	6532.01	7.34	0.22	36.80	20.02	0.00
Motilal Oswal Business Cycle Fund - Direct Plan - Growth	NA	1976.19	5.11	9.63	15.90	19.63	0.00
Franklin Asian Equity Fund - Direct - Growth	NA	259.99	5.99	13.23	16.59	19.23	13.74
Nippon India Japan Equity Fund - Direct Plan - Growth	NA	283.56	1.77	10.59	14.46	17.77	19.19
Nippon India US Equity Opportunities Fund - Direct Plan - Growth	NA	713.51	3.65	7.79	11.32	16.62	21.30
Motilal Oswal Manufacturing Fund - Direct Plan - Growth	NA	786.43	7.74	10.23	23.41	13.01	0.00
HDFC Transportation and Logistics Fund - Direct Plan - Growth	NA	1533.43	6.47	22.04	35.58	12.67	0.00
WhiteOak Capital Pharma and Healthcare Fund - Direct Plan - Growth	NA	423.51	0.52	9.10	13.20	12.01	0.00

Detailed Comparison

More Funds from HDFC Mutual Fund

Out of 86 mutual fund schemes offered by this AMC, 3 is/are ranked 5 * , 4 is/are ranked 4 * , 16 is/are ranked 3 * , 5 is/are ranked 2 * , 1 is/are ranked 1 * , and 57 schemes are not ranked. See more about AMC

Scheme Name	Crisil Rank	Asset Size (Cr)	1M	3M	6M	1Y	3Y
HDFC Balanced Advantage Fund - Direct Plan - Growth	4	101079.60	1.59	2.36	9.25	3.70	19.60
HDFC Mid Cap Fund - Direct Plan - Growth	4	83104.83	2.25	5.36	17.20	4.24	26.39
HDFC Flexi Cap Fund - Direct Plan - Growth	4	81935.61	2.18	5.37	14.35	7.20	23.70
HDFC Liquid Fund - Direct Plan - Growth	3	63201.14	0.47	1.44	3.32	6.93	7.05
HDFC Large Cap Fund - Direct Plan - Growth	3	37659.18	1.26	3.44	10.29	-1.96	17.35
HDFC Small Cap Fund - Direct Plan - Growth	3	36294.07	2.42	8.39	24.47	3.83	24.68
HDFC Money Market Fund - Direct Plan - Growth	2	36065.96	0.47	1.53	4.13	7.95	7.63
HDFC Corporate Bond Fund - Direct Plan - Growth	3	35821.39	0.44	0.89	4.23	7.92	7.91
HDFC Large and Mid Cap Fund - Direct Plan - Growth	3	26157.98	2.17	4.57	15.18	0.39	21.70
HDFC Low Duration Fund - Direct Plan - Growth	2	24720.51	0.44	1.50	4.28	8.10	7.78

All funds

Forum

hunch
MF Investment Help
Follow

29 days ago

JMFLEXICAPfund regular is howing worst performance. bought at 107.693 in jly 24 and now 97.43 how to shuffle and compensate loss View more

Posted by : hunch
- Like
- Reply
  
  reply Cancel
- Share
  
  276
- Repost
  
  Repost this message
  
  JMFLEXICAPfund regular is howing worst performance. bought at 107.693 in jly 24 and now 97.43 how to shuffle and compensate loss
  
  Repost Cancel
You will now receive notification when someone reply to this message.
shravanashok
MF Investment Help
Follow

44 days ago

need your suggestion for sbi psu fund direct growth stay or switch View more

Posted by : shravanashok
- Like
- Reply
  
  reply Cancel
- Share
  
  276
- Repost
  
  Repost this message
  
  need your suggestion for sbi psu fund direct growth stay or switch
  
  Repost Cancel
You will now receive notification when someone reply to this message.
The Fixed Income
Bonds
Follow

1 days ago

Short-Term, High-Yield Investment Opportunity ANNAPURNA FINANCE PRIVATE LIMITED – 2026 Bond ✔️ Coupon: 12.87% p.a. ✔️ Rating: CRISIL A- Stable ✔️ Tenor: 7m (Maturity: 02/May/2026) ✔️ NBFC | High Return | Listed A secured short-term bond delivering attractive returns—perfect for investors seeking quick maturity with strong yields. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dVJHcWJ3PT0=/1287-annapurna-finance-private-limited-2026?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list View more

Posted by : The Fixed Income
- Like
- Reply
  
  reply Cancel
- Share
  
  276
- Repost
  
  Repost this message
  
  Short-Term, High-Yield Investment Opportunity ANNAPURNA FINANCE PRIVATE LIMITED – 2026 Bond ✔️ Coupon: 12.87% p.a. ✔️ Rating: CRISIL A- Stable ✔️ Tenor: 7m (Maturity: 02/May/2026) ✔️ NBFC | High Return | Listed A secured short-term bond delivering attractive returns—perfect for investors seeking quick maturity with strong yields. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dVJHcWJ3PT0=/1287-annapurna-finance-private-limited-2026?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list
  
  Repost Cancel
You will now receive notification when someone reply to this message.
sunny85deol
MF Investment Help
Follow

95 days ago

Hello sir, I have been invested in these funds since 2017. Last SIP was in 2021. As their NAV have grown so I was thinking of switching to other funds with lower NAV. View more

Posted by : sunny85deol
- Like
- Reply
  
  reply Cancel
- Share
  
  276
- Repost
  
  Repost this message
  
  Hello sir, I have been invested in these funds since 2017. Last SIP was in 2021. As their NAV have grown so I was thinking of switching to other funds with lower NAV.
  
  Repost Cancel
You will now receive notification when someone reply to this message.
Progrowth Finwealth
MF Investment Help
Follow

95 days ago

Hi Sunny, what is he period of holding and also any particular reson for withdrawl out of these two funds that have grown over a period of time View more | 1

Posted by : Progrowth Finwealth
- Like
- Reply
  
  reply Cancel
- Share
  
  276
- Repost
  
  Repost this message
  
  Hi Sunny, what is he period of holding and also any particular reson for withdrawl out of these two funds that have grown over a period of time
  
  Repost Cancel
You will now receive notification when someone reply to this message.
h_purandare
MF Investment Help
Follow

101 days ago

Why are the NAVs of Indian Debt Mutual Funds going down after the rate cut View more

Posted by : h_purandare
- Like
- Reply
  
  reply Cancel
- Share
  
  276
- Repost
  
  Repost this message
  
  Why are the NAVs of Indian Debt Mutual Funds going down after the rate cut
  
  Repost Cancel
You will now receive notification when someone reply to this message.

+ See More